Aurora Cannabis (ACB) Enterprise Value (2018 - 2026)

Aurora Cannabis (ACB) has reported Enterprise Value for 9 consecutive years, with -$85.2 million the latest figure, recorded in Q1 2026.

• Quarterly Enterprise Value fell 26.75% year-over-year to -$85.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$85.2 million (down 26.75% YoY) and the FY2026 annual result came in at -$84.6 million, down 21.86% from the prior year.
• Enterprise Value declined to -$85.2 million in Q1 2026 per ACB's latest filing, from -$55.2 million in the prior quarter.
• Over the last five years, Enterprise Value for ACB reached as high as -$55.2 million in Q4 2025 and fell as low as -$363.6 million in Q2 2022.
• A 5-year average of -$149.2 million and a median of -$117.8 million in 2024 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2023 — Enterprise Value surged 60.83% — and 2026, when it decreased 26.75%.
• Year by year, Enterprise Value stood at -$180.8 million in 2022, then surged by 33.67% to -$119.9 million in 2023, then gained by 1.73% to -$117.8 million in 2024, then soared by 53.15% to -$55.2 million in 2025, then slumped by 54.42% to -$85.2 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$85.2 million, -$55.2 million, and -$77.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.